🇺🇸 FDA
Patent

US 6713444

Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus neurotoxins

expired A61KA61K38/00

Quick answer

US patent 6713444 (Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus neurotoxins) held by The United States of America as represented by the Secretary of the Army expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00